Clinical research - Press Releases

Date	Title	Company
13-Nov-2023	Resolution Therapeutics’ founders present clinical proof-of-concept for macrophage cell therapy in end-stage liver disease at AASLD	Resolution Therapeutics Limited
13-Nov-2023	Mission Therapeutics announces publication in Nature Communications outlining potential of experimental drug MTX325 as a disease-modifying therapy for Parkinson’s Disease	Mission Therapeutics
13-Nov-2023	KFSH&RC Succeeds in Applying Advanced Gene Therapy for Patients with Hemophilia	KFSH&RC
09-Nov-2023	Yourgene Health and Laboriad Launch Non-invasive Prenatal Testing in Morocco	ourgene Health and Laboriad
09-Nov-2023	AI image integrity tool now detects western band splicing	Proofig AI
09-Nov-2023	Game-changing non-invasive diagnostic solutions to be showcased at MEDICA 2023	Testcard
09-Nov-2023	Elsevier introduces authoritative scientific Datasets to fuel innovation and business-critical decisions in life sciences, chemicals and other research-intensive industries	Elsevier
09-Nov-2023	New Real-World Data Show TREMFYA® (guselkumab) Was Associated With Clinically Meaningful Improvements in Patient-Reported Outcomes for Adults Living With Active Psoriatic Arthritis	TREMFYA
07-Nov-2023	Futura expands partnership with M8 Pharmaceuticals for remainder of Central and South American region	Futura Medical plc
07-Nov-2023	Sosei Heptares’ President & CEO and Head of UK R&D to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2023	Sosei Heptares
07-Nov-2023	World’s first smart breathing tube for mechanically ventilated patients set for human trials	University of Nottingham
07-Nov-2023	ABB conveyor drive technology will enable LKAB underground mine to significantly increase energy efficiency	ABB Ltd
07-Nov-2023	Life Sciences event at Chelsea and Westminster Hospital	CW+
31-Oct-2023	Nouscom’s Off-the-Shelf Cancer Vaccine, NOUS-209, Shows Potential to ‘Intercept’ Cancer in Subjects with Lynch Syndrome	Nouscom
31-Oct-2023	Aqilion reports positive results from the ARIA-1 Phase 1 study in healthy subjects	Aqilion
30-Oct-2023	CD Bioparticles Launches New Line of Polystyrene Particles Conjugated with Biomolecules	CD Bioparticles
26-Oct-2023	Phastar Offers Pro Bono Support to Medicines Development for Global Health	Phastar
26-Oct-2023	Kancera reports that the phase I study of KAND145 has received regulatory approval	Kancera AB
26-Oct-2023	Mtech Access are returning to ISPOR Europe this November	Mtech Access
26-Oct-2023	Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth	Centricity Research